RayBiotech (RBI) has executed a master services and supply agreement with the Proteomics and Metabolomics Core Facility of Colorado State University in Fort Collin, Colorado. Under the deal, RayBiotech will offer biomarker discovery and ...
RayBiotech-developed antibody-based biomarker screening assays have been used to identify a critical pathway involved in chemotherapeutic resistance acquired by melanoma cancer cells. RayBiotech president and chief operating officer ...
Tags: medical research, clinical technology, RayBiotech's antibody arrays
RayBiotech has signed a master services agreement with a West Coast-based biopharmaceutical company to provide custom services in the area of preclinical research diagnostic testing. RayBiotech will leverage its antibody array ...
Tags: company cooperation, clinical technology, clinical service
RayBiotech, a developer of antibody and protein array technologies, has introduced a peptoid drug candidate and diagnostic ligand discovery service program. The new service platform, which is aimed at the identification of novel ligands ...
Tags: rayBiotech, peptoid, ligand, peptoid drug candidate